IL7 and glioblastoma: In conclusion, our study emphasizes the progressive suppression of the IL-7 pathway by CpG methylation in sequential GBM, suggesting that this mechanism may play a key role in immune evasion and supports its targeting by the engineering of novel immune therapies (Figure 1).